Can Small Molecule Inhibitors of Glutaminyl Cyclase Be Used as a Therapeutic for Alzheimer's Disease?

Future Medicinal Chemistry - United Kingdom
doi 10.4155/fmc-2017-0190
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Science Ltd

Related search

Platinum-Based Inhibitors of Amyloid- As Therapeutic Agents for Alzheimer's Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Can the Retina Be Used to Diagnose and Plot the Progression of Alzheimer's Disease?

Acta Ophthalmologica
MedicineOphthalmology
2017English

Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer’s Disease?

Neurotherapeutics
NeurologyPharmacology
2018English

Identification of a Mammalian Glutaminyl Cyclase Converting Glutaminyl Into Pyroglutamyl Peptides.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1987English

Vaccination as a Therapeutic Approach to Alzheimer's Disease

Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine
2010English

How Children Can Be Respected as 'Ends' Yet Still Be Used as Subjects in Non-Therapeutic Research.

Journal of Medical Ethics
ArtsHumanitiesLegal AspectsHealth PolicyHealthEthicsIssues
1986English

EGFR Inhibitors, MHC Expression and Immune Responses : Can EGFR Inhibitors Be Used as Immune Response Modifiers?

OncoImmunology
OncologyAllergyImmunology
2012English

Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimers Agents by Structure-Based Design

English

Derivatives of Piperazines as Potential Therapeutic Agents for Alzheimer's Disease

Molecular Pharmacology
Molecular MedicinePharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy